"UPMC Eye Center is a eye care center located in Pittsburgh .Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC Eye Center, Eye and Ear Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Eye Center, Eye and Ear Institute" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "University of Arizona" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UPMC Eye Center, Eye and Ear Institute" are "Carcinoma in Situ" (1 trials), "Dysplasia" (1 trials), "Head and Neck" (1 trials), "Head and Neck Cancer" (1 trials) and "Head and Neck Carcinoma" (1 trials). Many other conditions were trialed in "UPMC Eye Center, Eye and Ear Institute" in a lesser frequency.

Most popular intervention types in "UPMC Eye Center, Eye and Ear Institute" are "Drug" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avmacol" (1 trials), "Placebo" (1 trials), "S-217622" (1 trials), "binimetinib" (1 trials) and "encorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC Eye Center, Eye and Ear Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UPMC Eye Center, Eye and Ear Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UPMC Eye Center, Eye and Ear Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UPMC Eye Center, Eye and Ear Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".